ZEB1 and Miyoshi myopathy: Our study confirms this findings, demonstrating that the regulation of ZEB1 by DUBs constitutes a general mechanism driving cancer cells aggressiveness, which extends to hematological malignancies capable of acquiring EMT-like marker features, such as MM.